Source: European Journal of Contraception and Reproductive Health Care. Conference titles: Congress of the European Society of Contraception and Reproductive Health. Unidade: FMRP
Subjects: INFECÇÕES POR HIV, FARMACOTERAPIA, FARMACOCINÉTICA, MULHERES
ABNT
VIEIRA, Carolina Sales et al. Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on the etonogestrel-releasing implant pharmacokinetics in HIV-infected women. European Journal of Contraception and Reproductive Health Care. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 18 set. 2024. , 2014APA
Vieira, C. S., Bahamondes, M. V., Souza, R., Brito, M., Prandini, T., Amaral, E., et al. (2014). Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on the etonogestrel-releasing implant pharmacokinetics in HIV-infected women. European Journal of Contraception and Reproductive Health Care. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Vieira CS, Bahamondes MV, Souza R, Brito M, Prandini T, Amaral E, Bahamondes L, Duarte G, Quintana SM, Scaranari C, Ferriani RA. Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on the etonogestrel-releasing implant pharmacokinetics in HIV-infected women. European Journal of Contraception and Reproductive Health Care. 2014 ; 19 S72-S73.[citado 2024 set. 18 ]Vancouver
Vieira CS, Bahamondes MV, Souza R, Brito M, Prandini T, Amaral E, Bahamondes L, Duarte G, Quintana SM, Scaranari C, Ferriani RA. Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on the etonogestrel-releasing implant pharmacokinetics in HIV-infected women. European Journal of Contraception and Reproductive Health Care. 2014 ; 19 S72-S73.[citado 2024 set. 18 ]